1.68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?
Thabo LENGANA ; Ismaheel O LAWAL ; Kgomotso MOKOALA ; Mariza VORSTER ; Mike M SATHEKGE
Nuclear Medicine and Molecular Imaging 2019;53(6):442-445
We report a case of a 47-year-old female known with metastatic papillary thyroid cancer. Her treatment history included total thyroidectomy and 3 previous radio ablations with a cumulative dose of 950 mCi of ¹³¹I. On follow-up, her thyroglobulin levels had demonstrated a rising trend (from 3789.0 to 4240.0 ug/L) despite a ¹²³I whole-body scan demonstrating a reduction in tracer avid lesions. She was suspected of having radio-resistant disease. The patient underwent both ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT imaging with both scans demonstrating congruent lesions however with far greater intensity on the ⁶⁸Ga-PSMA study.
Female
;
Follow-Up Studies
;
Humans
;
Iodine
;
Middle Aged
;
Positron-Emission Tomography and Computed Tomography
;
Thyroglobulin
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
2.⁶⁸Gallium-Arginine-Glycine-Aspartic Acid and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull
Akintunde ORUNMUYI ; Moshe MODISELLE ; Thabo LENGANA ; Thomas EBENHAN ; Mariza VORSTER ; Mike SATHEKGE
Nuclear Medicine and Molecular Imaging 2017;51(3):271-273
We report the case of a 32 year-old male with Chondroblastic Osteosarcoma of the skull, which was imaged with both ¹⁸[F]fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography/computed tomography (PET/CT) and ⁶⁸Gallium-arginine-glycine-aspartic acid (⁶⁸Ga-RGD) PET/CT. The ¹⁸F-FDG PET/CT did not demonstrate the tumour,whereas the ⁶⁸Ga-RGD PET/CT clearly depicted a left-sided frontal tumour. ⁶⁸Ga-RGD PET/CT may be a clinically useful imaging modality for early detection of recurrent osteosarcoma, considering the limitations of ¹⁸F-FDG PET in a setting of low glycolytic activity.
Chondrocytes
;
Electrons
;
Humans
;
Male
;
Osteosarcoma
;
Positron-Emission Tomography and Computed Tomography
;
Skull
3.68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?
Thabo LENGANA ; Ismaheel O LAWAL ; Kgomotso MOKOALA ; Mariza VORSTER ; Mike M SATHEKGE
Nuclear Medicine and Molecular Imaging 2019;53(6):442-445
We report a case of a 47-year-old female known with metastatic papillary thyroid cancer. Her treatment history included total thyroidectomy and 3 previous radio ablations with a cumulative dose of 950 mCi of ¹³¹I. On follow-up, her thyroglobulin levels had demonstrated a rising trend (from 3789.0 to 4240.0 ug/L) despite a ¹²³I whole-body scan demonstrating a reduction in tracer avid lesions. She was suspected of having radio-resistant disease. The patient underwent both ¹â¸F-FDG and â¶â¸Ga-PSMA PET/CT imaging with both scans demonstrating congruent lesions however with far greater intensity on the â¶â¸Ga-PSMA study.